Literature DB >> 14633600

Successful immortalization of endometrial glandular cells with normal structural and functional characteristics.

Satoru Kyo1, Mitsuhiro Nakamura, Tohru Kiyono, Yoshiko Maida, Taro Kanaya, Masaaki Tanaka, Noriyuki Yatabe, Masaki Inoue.   

Abstract

The human endometrium is a dynamic tissue, the proliferative activity of which dramatically changes throughout the menstrual cycle, with exquisite regulation by sex-steroid hormones. Primary endometrial epithelial cells fall into senescence within 2 weeks when cultured on plastic dishes, and more complete understanding of endometrial biology has been delayed because of, in part, a lack of an in vitro culture model for endometrial epithelial cells. Our goal was to establish immortalized human endometrial glandular cells that retain the normal functions and characteristics of the primary cells. Because the Rb/p16 and p53 pathways are known to be critical elements of epithelial senescence in early passages, we used human papillomavirus E6/E7 to target these pathways. The combination of human papillomavirus-16 E6/E7 expression and telomerase activation by the introduction of human telomerase reverse transcriptase (hTERT) led to successful immortalization of the endometrial glandular cells. E6/E7 expression alone was sufficient to extend their life span more than 20 population doublings, but the telomerase activation was further required to enable the cells to pass through the subsequent replicative senescence at 40 population doublings. Isolated immortalized cells contained no chromosomal abnormalities or only nonclonal aberrations, retained responsiveness to sex-steroid hormones, exhibited glandular structure on three-dimensional culture, and lacked transformed phenotypes on soft agar or in nude mice. These findings support the notion that both Rb inactivation/p53 inactivation and telomerase activation are necessary to immortalize endometrial epithelial cells, but additional factors are required for endometrial carcinogenesis. Our established cell lines show great promise for investigation of hormone functions, endometrial biology, and endometrial carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633600      PMCID: PMC1892381          DOI: 10.1016/S0002-9440(10)63583-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments.

Authors:  G Saretzki; N Sitte; U Merkel; R E Wurm; T von Zglinicki
Journal:  Oncogene       Date:  1999-09-16       Impact factor: 9.867

2.  Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.

Authors:  S T Oh; S Kyo; L A Laimins
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Endometrial stromal cells regulate epithelial cell growth in vitro: a new co-culture model.

Authors:  J T Arnold; D G Kaufman; M Seppälä; B A Lessey
Journal:  Hum Reprod       Date:  2001-05       Impact factor: 6.918

4.  Evidence of the monoclonal composition of human endometrial epithelial glands and mosaic pattern of clonal distribution in luminal epithelium.

Authors:  Masaaki Tanaka; Satoru Kyo; Taro Kanaya; Noriyuki Yatabe; Mitsuhiro Nakamura; Yoshiko Maida; Masaru Okabe; Masaki Inoue
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

5.  Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres.

Authors:  M K Kang; W Guo; N H Park
Journal:  Cell Growth Differ       Date:  1998-01

6.  Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics.

Authors:  M A Dickson; W C Hahn; Y Ino; V Ronfard; J Y Wu; R A Weinberg; D N Louis; F P Li; J G Rheinwald
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

7.  Origin of concatemeric T7 DNA.

Authors:  J D Watson
Journal:  Nat New Biol       Date:  1972-10-18

Review 8.  Current molecular aspects of the carcinogenesis of the uterine endometrium.

Authors:  M Inoue
Journal:  Int J Gynecol Cancer       Date:  2001 Sep-Oct       Impact factor: 3.437

9.  Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway.

Authors:  Z Wang; S Kyo; M Takakura; M Tanaka; N Yatabe; Y Maida; M Fujiwara; J Hayakawa; M Ohmichi; K Koike; M Inoue
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

10.  A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.

Authors:  James G Rheinwald; William C Hahn; Matthew R Ramsey; Jenny Y Wu; Zongyou Guo; Hensin Tsao; Michele De Luca; Caterina Catricalà; Kathleen M O'Toole
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

View more
  50 in total

1.  Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells.

Authors:  Kazuo Asanoma; Ge Liu; Takako Yamane; Yoko Miyanari; Tomoka Takao; Hiroshi Yagi; Tatsuhiro Ohgami; Akimasa Ichinoe; Kenzo Sonoda; Norio Wake; Kiyoko Kato
Journal:  Mol Cell Biol       Date:  2015-09-21       Impact factor: 4.272

2.  Krüppel-like factor 4 mediates anti-proliferative effects of progesterone with G₀/G₁ arrest in human endometrial epithelial cells.

Authors:  Y Shimizu; T Takeuchi; S Mita; T Notsu; K Mizuguchi; S Kyo
Journal:  J Endocrinol Invest       Date:  2010-05-17       Impact factor: 4.256

3.  The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk.

Authors:  Marian Y Williams-Brown; Sana M Salih; Xia Xu; Timothy D Veenstra; Muhammad Saeed; Shaleen K Theiler; Concepcion R Diaz-Arrastia; Salama A Salama
Journal:  J Steroid Biochem Mol Biol       Date:  2011-05-10       Impact factor: 4.292

4.  Cryopreservation and recovery of human endometrial epithelial cells with high viability, purity, and functional fidelity.

Authors:  Joseph C Chen; Jacquelyn R Hoffman; Ripla Arora; Lila A Perrone; Christian J Gonzalez-Gomez; Kim Chi Vo; Diana J Laird; Juan C Irwin; Linda C Giudice
Journal:  Fertil Steril       Date:  2015-10-26       Impact factor: 7.329

5.  Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells: potential physiological and pathological relevance.

Authors:  Salama A Salama; Marwa W Kamel; Concepcion R Diaz-Arrastia; Xia Xu; Timothy D Veenstra; Sana Salih; Shaleen K Botting; Raj Kumar
Journal:  J Clin Endocrinol Metab       Date:  2008-10-28       Impact factor: 5.958

6.  Bis-Indole-Derived Nuclear Receptor 4A1 (NR4A1, Nur77) Ligands as Inhibitors of Endometriosis.

Authors:  Kumaravel Mohankumar; Xi Li; Nuri Sung; Yeon Jean Cho; Sang Jun Han; Stephen Safe
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

7.  Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer.

Authors:  N Mori; S Kyo; M Nakamura; M Hashimoto; Y Maida; Y Mizumoto; M Takakura; S Ohno; T Kiyono; M Inoue
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

8.  CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.

Authors:  Takamasa Uekita; Lin Jia; Mako Narisawa-Saito; Jun Yokota; Tohru Kiyono; Ryuichi Sakai
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

9.  LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment.

Authors:  Christopher G Peña; Yuji Nakada; Hatice D Saatcioglu; Gina M Aloisio; Ileana Cuevas; Song Zhang; David S Miller; Jayanthi S Lea; Kwok-Kin Wong; Ralph J DeBerardinis; Antonio L Amelio; Rolf A Brekken; Diego H Castrillon
Journal:  J Clin Invest       Date:  2015-09-28       Impact factor: 14.808

10.  MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents.

Authors:  Dawn R Cochrane; Nicole S Spoelstra; Erin N Howe; Steven K Nordeen; Jennifer K Richer
Journal:  Mol Cancer Ther       Date:  2009-05-12       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.